Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

277
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
277
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

192
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
192
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

307
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
307
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

970
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
970

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extraosseous Ewing Sarcoma in a 28-Year-Old Male: A Case Report and Literature Review.

Cureus·2024
Same author

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Discovery, Significance, and Utility of JAK2 Mutation in Squamous Cell Carcinoma of the Lung.

Cureus·2022
Same author

Primary central nervous system diffuse large B-cell lymphoma masqueraded as Bing-Neel syndrome: Steps in management and review of future directions.

Clinical case reports·2021
Same author

Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts.

American journal of hematology·2021
Same author

An Unusual Hodgkin's Lymphoma Journey: Cardiac Tamponade, Primary Refractoriness, Immune Thrombocytopenia, and Post-Traumatic Stress Disorder.

Cureus·2021

Related Experiment Videos

Paraneoplastic Demyelinating Neuropathy, a Multifactorial Disease and Approach to Management.

Abigael Luke, James Vredenburgh

    Connecticut Medicine
    |June 14, 2018
    PubMed
    Summary

    A paraneoplastic syndrome caused severe neuropathy in a patient with lymphoplasmacytic lymphoma. Treatment targeting both the malignancy and immune attack led to significant recovery.

    Related Experiment Videos

    Area of Science:

    • Neurology
    • Oncology
    • Immunology

    Background:

    • Paraneoplastic syndromes can manifest as immune-mediated neurological disorders.
    • Lymphoplasmacytic lymphoma is a B-cell malignancy associated with plasma cell dyscrasia.

    Observation:

    • A 53-year-old male presented with demyelinating polyneuropathy, a potential paraneoplastic complication.
    • The patient experienced severe neurological deficits, including near quadriplegia, necessitating mechanical ventilation.

    Findings:

    • The patient's condition was linked to an immune-mediated event stemming from lymphoplasmacytic lymphoma.
    • Combined systemic therapy for the malignancy and immunomodulatory treatment resulted in substantial neurological recovery.

    Implications:

    • Effective management requires addressing both the underlying plasma cell dyscrasia and the specific immune targets.
    • Targeting peripheral antibodies is crucial for preventing further nervous system damage in similar cases.